SEC Filings | Zevra Therapeutics, Inc.

Filing date	Form	Description	Filing Group	View
03-21-2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001437749-23-007397.rtf 0001437749-23-007397.xls 0001437749-23-007397.pdf View HTML
03-17-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-006961.rtf 0001437749-23-006961.xls 0001437749-23-006961.pdf View HTML
03-17-2023	DEFC14A	Definitive proxy statement in connection with contested solicitations	Proxy Filings	0001477932-23-001547.rtf 0001477932-23-001547.xls 0001477932-23-001547.pdf View HTML
03-16-2023	PRRN14A	Non-management revised preliminary proxy soliciting materials	Proxy Filings	0001477932-23-001508.rtf 0001477932-23-001508.xls 0001477932-23-001508.pdf View HTML
03-16-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-006905.rtf 0001437749-23-006905.xls 0001437749-23-006905.pdf View HTML
03-15-2023	DEFC14A	Definitive proxy statement in connection with contested solicitations	Proxy Filings	0001437749-23-006586.rtf 0001437749-23-006586.xls 0001437749-23-006586.pdf View HTML
03-15-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-006593.rtf 0001437749-23-006593.xls 0001437749-23-006593.pdf View HTML
03-15-2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001437749-23-006771.rtf 0001437749-23-006771.xls 0001437749-23-006771.pdf View HTML
03-13-2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001437749-23-006250.rtf 0001437749-23-006250.xls 0001437749-23-006250.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
03-13-2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001437749-23-006274.rtf 0001437749-23-006274.xls 0001437749-23-006274.pdf View HTML

Filing Group

View

03-21-2023